Stereotactic Radiosurgery for Benign Cavernous Sinus Meningiomas: A Multicentre Study and Review of the Literature.

Détails

Ressource 1Télécharger: 2022_Stereotactic Radiosurgery for Benign Cavernous Sinus Meningiomas- A Multicentre Study and Review of the Literature.pdf (1735.50 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_940AB6DB4859
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Stereotactic Radiosurgery for Benign Cavernous Sinus Meningiomas: A Multicentre Study and Review of the Literature.
Périodique
Cancers
Auteur⸱e⸱s
Santacroce A., Tuleasca C., Liščák R., Motti E., Lindquist C., Radatz M., Gatterbauer B., Lippitz B.E., Martínez Álvarez R., Martínez Moreno N., Kamp M.A., Sandvei Skeie B., Schipmann S., Longhi M., Unger F., Sabin I., Mindermann T., Bundschuh O., Horstmann G.A., van Eck ATCJ, Walier M., Berres M., Nakamura M., Steiger H.J., Hänggi D., Fortmann T., Zawy Alsofy S., Régis J., Ewelt C.
ISSN
2072-6694 (Print)
ISSN-L
2072-6694
Statut éditorial
Publié
Date de publication
22/08/2022
Peer-reviewed
Oui
Volume
14
Numéro
16
Pages
4047
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Résumé
Cavernous sinus meningiomas (CSMs) remain a surgical challenge due to the intimate involvement of their contained nerves and blood vessels. Stereotactic radiosurgery (SRS) is a safe and effective minimally invasive alternative for the treatment of small- to medium-sized CSMs. Objective: To assess the medium- to long-term outcomes of SRS for CSMs with respect to tumour growth, prevention of further neurological deterioration and improvement of existing neurological deficits. This multicentric study included data from 15 European institutions. We performed a retrospective observational analysis of 1222 consecutive patients harbouring 1272 benign CSMs. All were treated with Gamma Knife stereotactic radiosurgery (SRS). Clinical and imaging data were retrieved from each centre and entered into a common database. All tumours with imaging follow-up of less than 24 months were excluded. Detailed results from 945 meningiomas (86%) were then analysed. Clinical neurological outcomes were available for 1042 patients (85%). Median imaging follow-up was 67 months (mean 73.4, range 24-233). Median tumour volume was 6.2 cc (+/-7), and the median marginal dose was 14 Gy (+/-3). The post-treatment tumour volume decreased in 549 (58.1%), remained stable in 336 (35.6%) and increased in only 60 lesions (6.3%), yielding a local tumour control rate of 93.7%. Only 27 (2.8%) of the 60 enlarging tumours required further treatment. Five- and ten-year actuarial progression-free survival (PFS) rates were 96.7% and 90.1%, respectively. Tumour control rates were higher for women than men (p = 0.0031), and also for solitary sporadic meningiomas (p = 0.0201). There was no statistically significant difference in outcome for imaging-defined meningiomas when compared with histologically proven WHO Grade-I meningiomas (p = 0.1212). Median clinical follow up was 61 months (mean 64, range 6-233). Permanent morbidity occurred in 5.9% of cases at last follow-up. Stereotactic radiosurgery is a safe and effective method for treating benign CSM in the medium term to long term.
Mots-clé
Cancer Research, Oncology, Gamma Knife, cavernous sinus, meningioma, multicentre study, stereotactic radiosurgery
Pubmed
Web of science
Open Access
Oui
Création de la notice
24/08/2022 19:22
Dernière modification de la notice
11/03/2023 8:12
Données d'usage